- Poseida Therapeutics Inc P-BCMA-ALLO1 Clinical Data Call TranscriptDec 10, 2023
- Poseida Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference TranscriptSep 26, 2023
- Poseida Therapeutics Inc at Stifel Tailoring Genes: Genetic Medicines Day (Virtual) TranscriptMay 30, 2023
- Poseida Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Poseida Therapeutics Inc at HC Wainwright Cell Therapy Virtual Conference TranscriptFeb 28, 2023
- Poseida Therapeutics Inc at Piper Sandler Healthcare Conference TranscriptNov 30, 2022
- Poseida Therapeutics Inc at Stifel Healthcare Conference TranscriptNov 16, 2022
- Poseida Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Poseida Therapeutics Inc Collaboration and Poseida's Novel Approach to Allogeneic Cell Therapy - Corporate Call TranscriptAug 03, 2022
- Poseida Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
Poseida Therapeutics Inc at Bank of America Global Healthcare Conference Transcript
Let's get going. Hey, everyone. Welcome to day two of the 2023 BofA Healthcare Conference. Thanks for joining the session with Poseida Therapeutics. My name is Alec Stranahan. I'm Vice President and Senior Biotech Analyst covering Poseida here at BofA. And I'm pleased to be joined today by Mark Gergen, Chairman and Chief Executive Officer of Poseida. Mark, thanks for joining.
Thanks for having us. Happy to be here.
Questions & Answers
Perfect. So given we've got 15 minutes, we'll just jump straight into the Q&A. But if anyone in the audience has a question, feel free to raise your hand and we'll bring you a mic and you can ask it throughout.
So Mark, maybe just to start, you guys have some pretty high-profile collaborations, Roche, Takeda. How should we be thinking about timelines, study starts, time to data for these partnered assets and maybe the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)